Abstract
Breast conserving therapy (BCT) has become an accepted option in the management of patients with early-stage breast cancer. However, studies have suggested that a lengthy course of adjuvant whole breast irradiation, as a component of BCT, may not always be necessary and that radiation therapy delivered only to the region of the tumor bed may be acceptable in appropriately selected patients. Several modalities are currently being explored as a means to deliver accelerated partial breast irradiation (APBI), including multicatheter interstitial brachytherapy, the MammoSite breast brachytherapy catheter (Cytyc Corporation, Marlborough, MA), and three-dimensional conformal external-beam radiation therapy. To date, phase 1/2 published data have demonstrated excellent local control rates and cosmesis. As additional data addressing the effectiveness of this treatment approach accumulate, a new standard of care may emerge. This review discusses data accumulated to date exploring the experience with all APBI modalities and presents future studies exploring this concept.
Similar content being viewed by others
References and Recommended Reading
Fisher B, Anderson S, Bryant J, et al.: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233–1241.
van Dongen JA, Voogd AC, Fentiman IS, et al.: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000, 92:1143–1150.
Smith TE, Lee D, Turner BC, et al.: True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000, 48:1281–1289.
Huang E, Buchholz TA, Meric F, et al.: Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 2002, 95:2059–2067.
Fowble B, Solin LJ, Schultz DJ, et al.: Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 1990, 19:833–842.
Gage I, Recht A, Gelman R, et al.: Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995, 33:245–251.
Nattinger AB, Gottlieb MS, Veum J, et al.: Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 1992, 326:1102–1107.
Legorreta AP, Liu X, Parker RG: Examining the use of breast-conserving treatment for women with breast cancer in a managed care environment. Am J Clin Oncol 2000, 23:438–441.
Hiotis K, Ye W, Sposto R, Skinner KA: Predictors of breast conservation therapy: size is not all that matters. Cancer 2005, 103:892–899.
Morrow M, Bucci C, Rademaker A: Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 1998, 186:269–274.
Farrow DC, Hunt WC, Samet JM: Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992, 326:1097–1101.
Lazovich DA, White E, Thomas DB, Moe RE: Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991, 266:3433–3438.
Mann BA, Samet JM, Hunt WC, et al.: Changing treatment of breast cancer in New Mexico from 1969 through 1985. JAMA 1988, 259:3413–3417.
Ballard-Barbash R, Potosky AL, Harlan LC, et al.: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996, 88:716–726.
Kuerer HM, Julian TB, Strom EA, et al.: Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg 2004, 239:338–351.
Albain KS, Green SR, Lichter AS, et al.: Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol 1996, 14:3009–3017.
American Brachytherapy Society: Breast Brachytherapy Task Group guidelines. February 2007. http://www.americanbrachytherapy.org/resources/abs_breast_brachytherapy_taskgroup.pdf. Accessed October 29, 2007.
Zannis V, Beitsch P, Vicini F, et al.: Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry trial. Am J Surg 2005, 190:530–538.
NSABP Clinical Trials overview. NSABP website. http://www.nsabp.pitt.edu/B-39.asp. Accessed October 29, 2007.
King TA, Bolton JS, Kuske RR, et al.: Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000, 180:299–304.
Vicini FA, Kestin L, Chen P, et al.: Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003, 95:1205–1210.
Chen PY, Vicini FA, Benitez P, et al.: Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 2006, 106:991–999.
Kuske RR, Winter K, Arthur DW, et al.: Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys 2006, 65:45–51.
Kuske RR, Winter K, Arthur DW, et al.: A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: initial outcomes of RTOG 95-17 [ASCO abstract 565]. J Clin Oncol 2004, 22(14S):abstract 565.
Keisch M, Vicini F, Kuske R, et al.: Two-year outcome with the MammoSite breast brachytherapy applicator: factors associated with optimal cosmetic results when performing partial breast irradiation [abstract]. Int J Radiat Oncol Biol Phys 2003, 57(Suppl):S315.
Keisch ME, Vicini F, Beitsch P, et al.: Two year actuarial analysis of 198 patients with DCIS treated with accelerated partial breast irradiation (APBI): efficacy, cosmesis and toxicity in patients in the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry trial. Int J Radiat Oncol Biol Phys 2006, 66:S213.
Benitez PR, Streeter O, Vicini F, et al.: Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg 2006, 192:427–433.
Wernicke AG, Gidea-Addeo D, Magnolfi C, et al.: External beam partial breast irradiation following breast-conserving surgery: preliminary results of cosmetic outcome of NYU 00-23. Int J Radiat Oncol Biol Phys 2006, 66:S32.
Vicini F, Winter K, Straube W, et al.: A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) study 0319. Int J Radiat Oncol Biol Phys 2005, 63:1531–1537.
Reitsamer R, Peintinger F, Sedlmayer F, et al.: Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients. Eur J Cancer 2002, 38:1607–1610.
Pignol JP, Keller B, Rakovitch E, et al.: First report of a permanent breast 103Pd seed implant as adjuvant radiation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2006, 64:176–181.
Godinez J, Gombos EC: A permanent breast seed implant as partial-breast radiation therapy for early-stage patients: in regards to Keller et al. (Int J Radiat Oncol Biol Phys 2005;62:358–365). Int J Radiat Oncol Biol Phys 2006, 64:1611.
Taghian AG, Kozak KR, Katz A, et al.: Accelerated partial breast irradiation using proton beams: initial dosimetric experience. Int J Radiat Oncol Biol Phys 2006, 65:1404–1410.
Polgár C, Fodor J, Major T, et al.: Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 2007, 69:694–702.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Swanson, T.A., Vicini, F.A. Overview of accelerated partial breast irradiation. Curr Oncol Rep 10, 54–60 (2008). https://doi.org/10.1007/s11912-008-0009-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11912-008-0009-8